Philipp Erben
Impact in
- Hematology top 0.2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Rheumatology top 2%
- Eosinophilic Disorders and Syndromes
Papers in
- Hematology 60
- Chronic Myeloid Leukemia Treatments 56
- Surgery 58
- Bladder and Urothelial Cancer Treatments 56
- Co-authors
- Andreas Hochhaus (64 shared papers)Martin C. Müller (20 shared papers)Thomas Ernst (21 shared papers)Nicholas C.P. Cross (17 shared papers)Susan Branford (8 shared papers)Jörge E. Cortes (6 shared papers)Giuseppe Nicola Saglio (11 shared papers)Andreas Reiter (21 shared papers)
- Journals
- Blood (40 papers)Leukemia (10 papers)Haematologica (8 papers)Journal of Cancer Research and Clinical Oncology (6 papers)Annals of Hematology (6 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Philipp Erben
182 papers receiving 5.9k citations
Philipp Erben's Hit Papers
Peers
Comparison fields: 5 of 94
- Hematology 2.8k
- Rheumatology 522
- Oncology 609
- Genetics 217
- Immunology 390
Countries citing papers authored by Philipp Erben
This map shows the geographic impact of Philipp Erben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Erben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Erben more than expected).
Fields of papers citing papers by Philipp Erben
This network shows the impact of papers produced by Philipp Erben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Erben. The network helps show where Philipp Erben may publish in the future.
Co-authors
The 25 scholars most cited alongside Philipp Erben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 187 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 348 | |
| 2 | 2006 | 330 | |
| 3 | 2009 | 262 | |
| 4 | 2009 | 254 | |
| 5 | 2013 | 219 | |
| 6 | 2009 | 179 | |
| 7 | 2009 | 166 | |
| 8 | 2007 | 158 | |
| 9 | Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance Hit paper breakdown → | 2022 | 157 |
| 10 | 2019 | 152 | |
| 11 | 2010 | 140 | |
| 12 | 2007 | 131 | |
| 13 | 2006 | 125 | |
| 14 | 2013 | 119 | |
| 15 | 2014 | 116 | |
| 16 | 2010 | 105 | |
| 17 | 2008 | 104 | |
| 18 | 2014 | 104 | |
| 19 | 2008 | 96 | |
| 20 | 2007 | 93 |
About Philipp Erben
Philipp Erben is a scholar working on Hematology, Surgery, Rheumatology, Oncology and Genetics, having authored 187 papers that have together received 6.1k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (56 papers), Bladder and Urothelial Cancer Treatments (56 papers), Eosinophilic Disorders and Syndromes (18 papers), Cancer Immunotherapy and Biomarkers (8 papers), Colorectal Cancer Surgical Treatments (7 papers), Prostate Cancer Treatment and Research (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Mast cells and histamine (5 papers). The work is most often cited by research in Hematology (2.8k citations), Rheumatology (522 citations), Oncology (609 citations), Genetics (217 citations) and Immunology (390 citations). Philipp Erben has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Andreas Hochhaus, Martin C. Müller, Thomas Ernst, Nicholas C.P. Cross, Susan Branford, Jörge E. Cortes, Giuseppe Nicola Saglio, Andreas Reiter, Rüdiger Hehlmann and Dong‐Wook Kim. Their work appears in journals such as Blood, Leukemia, Haematologica, Journal of Cancer Research and Clinical Oncology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.